{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:49:21Z","timestamp":1791413361932,"version":"4.3.3"},"reference-count":45,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.antiviral.2013.03.023","type":"journal-article","created":{"date-parts":[[2013,4,8]],"date-time":"2013-04-08T08:46:30Z","timestamp":1365410790000},"page":"432-440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Small molecule inhibitors of ER \u03b1-glucosidases are active against multiple hemorrhagic fever viruses"],"prefix":"10.1016","volume":"98","author":[{"given":"Jinhong","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis K.","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuesen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ann","family":"Comunale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanming","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic S.","family":"Alonzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenquan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Tao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cuconati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry D.","family":"Butters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sina","family":"Bavari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.antiviral.2013.03.023_b0005","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1042\/BJ20070748","article-title":"Glucosylated free oligosaccharides are biomarkers of endoplasmic-reticulum alpha-glucosidase inhibition","volume":"409","author":"Alonzi","year":"2008","journal-title":"Biochem. J."},{"issue":"6","key":"10.1016\/j.antiviral.2013.03.023_b0010","doi-asserted-by":"crossref","first-page":"694","DOI":"10.4161\/hv.7.6.15198","article-title":"Argentine hemorrhagic fever vaccines","volume":"7","author":"Ambrosio","year":"2011","journal-title":"Hum. Vaccin."},{"issue":"6","key":"10.1016\/j.antiviral.2013.03.023_b0015","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/095632020101200601","article-title":"Iminosugars as possible broad spectrum anti hepatitis virus agents: the glucovirs and alkovirs","volume":"12","author":"Block","year":"2001","journal-title":"Antiviral Chem. Chemother."},{"issue":"6","key":"10.1016\/j.antiviral.2013.03.023_b0020","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1073\/pnas.91.6.2235","article-title":"Secretion of human hepatitis B virus is inhibited by the imino sugar N-butyldeoxynojirimycin","volume":"91","author":"Block","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.antiviral.2013.03.023_b0025","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.cld.2007.08.002","article-title":"Molecular virology of hepatitis B virus for clinicians","volume":"11","author":"Block","year":"2007","journal-title":"Clin. Liver Dis."},{"issue":"18","key":"10.1016\/j.antiviral.2013.03.023_b0030","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1001\/jama.287.18.2391","article-title":"Hemorrhagic fever viruses as biological weapons: medical and public health management","volume":"287","author":"Borio","year":"2002","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.antiviral.2013.03.023_b0035","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.coi.2005.05.001","article-title":"Pathogenesis of viral hemorrhagic fever","volume":"17","author":"Bray","year":"2005","journal-title":"Curr. Opin. Immunol."},{"issue":"2","key":"10.1016\/j.antiviral.2013.03.023_b0040","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/glycob\/5.2.249","article-title":"The effect of oral treatment with 6-O-butanoyl castanospermine (MDL 28,574) in the murine zosteriform model of HSV-1 infection","volume":"5","author":"Bridges","year":"1995","journal-title":"Glycobiology"},{"issue":"4","key":"10.1016\/j.antiviral.2013.03.023_b0045","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1128\/AAC.01457-08","article-title":"Novel imino sugar derivatives demonstrate potent antiviral activity against flaviviruses","volume":"53","author":"Chang","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"issue":"1","key":"10.1016\/j.antiviral.2013.03.023_b0050","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.antiviral.2010.11.002","article-title":"Combination of alpha-glucosidase inhibitor and ribavirin for the treatment of dengue virus infection in vitro and in vivo","volume":"89","author":"Chang","year":"2011","journal-title":"Antiviral Res."},{"issue":"2","key":"10.1016\/j.antiviral.2013.03.023_b0055","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.antiviral.2011.08.003","article-title":"Competitive inhibitor of cellular alpha-glucosidases protects mice from lethal dengue virus infection","volume":"92","author":"Chang","year":"2011","journal-title":"Antiviral Res."},{"issue":"2","key":"10.1016\/j.antiviral.2013.03.023_b0060","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1006\/viro.1995.1016","article-title":"Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes","volume":"206","author":"Connor","year":"1995","journal-title":"Virology"},{"issue":"7364","key":"10.1016\/j.antiviral.2013.03.023_b0065","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature10380","article-title":"Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection","volume":"477","author":"Cote","year":"2011","journal-title":"Nature"},{"issue":"1\u20132","key":"10.1016\/j.antiviral.2013.03.023_b0070","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF01309294","article-title":"On the role of oligosaccharide trimming in the maturation of Sindbis and influenza virus","volume":"81","author":"Datema","year":"1984","journal-title":"Arch. Virol."},{"issue":"8","key":"10.1016\/j.antiviral.2013.03.023_b0075","first-page":"860","article-title":"Celgosivir, an alpha-glucosidase I inhibitor for the potential treatment of HCV infection","volume":"10","author":"Durantel","year":"2009","journal-title":"Curr. Opin. Invest. Drugs"},{"issue":"1","key":"10.1016\/j.antiviral.2013.03.023_b0080","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrd708","article-title":"Targeting glycosylation as a therapeutic approach","volume":"1","author":"Dwek","year":"2002","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2013.03.023_b0085","unstructured":"EMEA (2003). Scientific Discussion \u2013 Zavesca."},{"issue":"9693","key":"10.1016\/j.antiviral.2013.03.023_b0090","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0140-6736(09)61260-5","article-title":"Beyond HAART: scientists and activists need to work together","volume":"374","author":"Geffen","year":"2009","journal-title":"Lancet"},{"issue":"Suppl. 12","key":"10.1016\/j.antiviral.2013.03.023_b0095","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1038\/nm1142","article-title":"Exotic emerging viral diseases: progress and challenges","volume":"10","author":"Geisbert","year":"2004","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.antiviral.2013.03.023_b0100","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/095632020701800105","article-title":"Antiviral profiles of novel iminocyclitol compounds against bovine viral diarrhea virus, West Nile virus, dengue virus and hepatitis B virus","volume":"18","author":"Gu","year":"2007","journal-title":"Antiviral Chem. Chemother."},{"issue":"11","key":"10.1016\/j.antiviral.2013.03.023_b0105","doi-asserted-by":"crossref","first-page":"6705","DOI":"10.1128\/JVI.69.11.6705-6711.1995","article-title":"Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity","volume":"69","author":"He","year":"1995","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2013.03.023_b0110","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1146\/annurev.biochem.73.011303.073752","article-title":"Roles of N-linked glycans in the endoplasmic reticulum","volume":"73","author":"Helenius","year":"2004","journal-title":"Ann. Rev. Biochem."},{"issue":"Suppl. 1","key":"10.1016\/j.antiviral.2013.03.023_b0115","doi-asserted-by":"crossref","first-page":"S240","DOI":"10.1086\/514316","article-title":"Antiviral drug therapy of filovirus infections: S-adenosylhomocysteine hydrolase inhibitors inhibit Ebola virus in vitro and in a lethal mouse model","volume":"179","author":"Huggins","year":"1999","journal-title":"J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.antiviral.2013.03.023_b0120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1006\/viro.2002.1370","article-title":"Inhibition of host ER glucosidase activity prevents Golgi processing of virion-associated bovine viral diarrhea virus E2 glycoproteins and reduces infectivity of secreted virions","volume":"295","author":"Jordan","year":"2002","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.antiviral.2013.03.023_b0125","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0021-9258(18)54189-2","article-title":"Effects of the imino sugar N-butyldeoxynojirimycin on the N-glycosylation of recombinant gp120","volume":"268","author":"Karlsson","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 3","key":"10.1016\/j.antiviral.2013.03.023_b0130","doi-asserted-by":"crossref","first-page":"S810","DOI":"10.1093\/infdis\/jir299","article-title":"Basic clinical and laboratory features of filoviral hemorrhagic fever","volume":"204","author":"Kortepeter","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"Suppl. 4","key":"10.1016\/j.antiviral.2013.03.023_b0135","doi-asserted-by":"crossref","first-page":"S730","DOI":"10.1093\/clinids\/11.Supplement_4.S730","article-title":"Epidemiology of hemorrhagic fever viruses","volume":"11","author":"LeDuc","year":"1989","journal-title":"Rev. Infect. Dis."},{"issue":"8","key":"10.1016\/j.antiviral.2013.03.023_b0140","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1473-3099(04)01103-X","article-title":"Pathogenesis of filoviral haemorrhagic fevers","volume":"4","author":"Mahanty","year":"2004","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.antiviral.2013.03.023_b0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/viro.1994.1157","article-title":"The role of N-glycosylation in cell fusion induced by a vaccinia recombinant virus expressing both measles virus glycoproteins","volume":"200","author":"Malvoisin","year":"1994","journal-title":"Virology"},{"issue":"Pt 3","key":"10.1016\/j.antiviral.2013.03.023_b0150","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1042\/BJ20031824","article-title":"Cellular effects of deoxynojirimycin analogues: inhibition of N-linked oligosaccharide processing and generation of free glucosylated oligosaccharides","volume":"381","author":"Mellor","year":"2004","journal-title":"Biochem. J."},{"issue":"3","key":"10.1016\/j.antiviral.2013.03.023_b0155","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1128\/AAC.01319-10","article-title":"Inhibitors of Endoplasmic Reticulum {alpha}-Glucosidases Potently Suppress Hepatitis C Virus Virion Assembly and Release","volume":"55","author":"Qu","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"17","key":"10.1016\/j.antiviral.2013.03.023_b0160","doi-asserted-by":"crossref","first-page":"8502","DOI":"10.1128\/JVI.02600-10","article-title":"Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry","volume":"85","author":"Radoshitzky","year":"2011","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.antiviral.2013.03.023_b0165","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.antiviral.2011.10.002","article-title":"Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model","volume":"92","author":"Rathore","year":"2011","journal-title":"Antiviral Res."},{"issue":"Suppl. 3","key":"10.1016\/j.antiviral.2013.03.023_b0170","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2362.1994.tb02251.x","article-title":"An evaluation of the potential side-effects of alpha-glucosidase inhibitors used for the management of diabetes mellitus","volume":"24","author":"Reuser","year":"1994","journal-title":"Eur. J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.antiviral.2013.03.023_b0175","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1086\/511310","article-title":"A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs","volume":"195","author":"Schul","year":"2007","journal-title":"J. Infect. Dis."},{"issue":"7241","key":"10.1016\/j.antiviral.2013.03.023_b0180","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/nature07967","article-title":"Discovery of insect and human dengue virus host factors","volume":"458","author":"Sessions","year":"2009","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.antiviral.2013.03.023_b0185","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/hep.21686","article-title":"Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus","volume":"46","author":"Steinmann","year":"2007","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.antiviral.2013.03.023_b0190","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/00002030-199106000-00008","article-title":"6-0-butanoylcastanospermine (MDL 28,574) inhibits glycoprotein processing and the growth of HIVs","volume":"5","author":"Taylor","year":"1991","journal-title":"AIDS"},{"issue":"11","key":"10.1016\/j.antiviral.2013.03.023_b0195","doi-asserted-by":"crossref","first-page":"e1000212","DOI":"10.1371\/journal.ppat.1000212","article-title":"Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda","volume":"4","author":"Towner","year":"2008","journal-title":"PLoS Pathog."},{"issue":"5","key":"10.1016\/j.antiviral.2013.03.023_b0200","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1128\/AAC.01315-09","article-title":"Antiviral activity of a small-molecule inhibitor of filovirus infection","volume":"54","author":"Warren","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"issue":"9","key":"10.1016\/j.antiviral.2013.03.023_b0205","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nm.2202","article-title":"Advanced antisense therapies for postexposure protection against lethal filovirus infections","volume":"16","author":"Warren","year":"2010","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.antiviral.2013.03.023_b0210","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.antiviral.2012.07.008","article-title":"Dose- and schedule-dependent protective efficacy of celgosivir in a lethal mouse model for dengue virus infection informs dosing regimen for a proof of concept clinical trial","volume":"96","author":"Watanabe","year":"2012","journal-title":"Antiviral Res."},{"issue":"8","key":"10.1016\/j.antiviral.2013.03.023_b0215","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1128\/JVI.76.8.3596-3604.2002","article-title":"Antiviral effects of an iminosugar derivative on flavivirus infections","volume":"76","author":"Wu","year":"2002","journal-title":"J. Virol."},{"issue":"13","key":"10.1016\/j.antiviral.2013.03.023_b0220","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.1021\/jm300171v","article-title":"Design, synthesis, and biological evaluation of N-Alkylated Deoxynojirimycin (DNJ) derivatives for the treatment of dengue virus infection","volume":"55","author":"Yu","year":"2012","journal-title":"J. Med. Chem."},{"issue":"21","key":"10.1016\/j.antiviral.2013.03.023_b0225","doi-asserted-by":"crossref","first-page":"11878","DOI":"10.1073\/pnas.96.21.11878","article-title":"Imino sugars inhibit the formation and secretion of bovine viral diarrhea virus, a pestivirus model of hepatitis C virus: implications for the development of broad spectrum anti-hepatitis virus agents","volume":"96","author":"Zitzmann","year":"1999","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213000867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354213000867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T12:51:37Z","timestamp":1715172697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354213000867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":45,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0166354213000867"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.03.023","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small molecule inhibitors of ER \u03b1-glucosidases are active against multiple hemorrhagic fever viruses","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2013.03.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}